SphereBio

Training Immune
Cells to End Cancer

we are developing personalized cancer
therapeutics to train the immune cells
to attack the tumor.

Learn more
hero image
arrowsarrows
challenge
challenge
challenge
Challenge

Revolutionizing Healthcare with smart, cutting-edge technology:

Every year, millions die because of cancer. Current therapies are still failing to provide an effective and lasting treatment for the disease.
Our mission is to provide a solution that is
Precise | Personalized | Directed
This means fewer side effects, increased efficacy, and most importantly, more lives saved.

Solution

Efficient Biotech Delivery Platform Specifically Designed to Expose Tumor Unique Identity

Our biotech delivery platform efficiently delivers molecules to cells, training them to generate specific responses to recognize and kill the elusive cancer cells. Currently, we are using our platform to offer pharmaceutical companies a novel approach to provide treatment alternatives specifically designed to take into account each patient's disease singularity.

solution
Technology

Bridging the gap between health and technology

We use Bioinformatics algorithms to decode each tumor, find patterns, and decide the best therapy for each patient.

Our delivery platforms combine synthetic virology with nanotechnology to send these

messages to our cells in a very efficient manner.

We're not offering a one-size-fits-all solution, but a tailored approach to fight each individual's cancer or disease.

We use bioinformatics to design the molecules that we will deliver.
In this way, we write the message that our cells must receive to respond in a given way.

Our delivery platforms combine synthetic virology with nanotechnology to sent these messages to our cells in a very efficient manner.

What is our next step? To make these technologies even simpler and more reliable to definitely change the way we create vaccines and therapeutics.

bioinformaticsbioinformatics
synthetic virologysynthetic virology
nanotechnologynanotechnology
mission
left arrow

01. Our Mission & Vision

Our mission is to make a lasting impact on the lives of patients and their loved ones by delivering groundbreaking, personalized cancer vaccines. We are dedicated to fighting cancer one patient at a time, ensuring that every life we touch is treated with the utmost care and consideration, driven by our commitment to innovation, efficacy, and individualized care.

02. Our Mission & Vission

To revolutionize the healthcare landscape, prioritizing safety and reliability, as we harness the power of personalized medicine.
We envision a world where the uniqueness of each patient is the cornerstone of their treatment, transforming the fight against cancer with precision and compassion.

left arrowright arrow
Team

From diverse backgrounds to common ideals

At SphereBio, we have assembled a founding team of young and passionate professionals with a shared goal: to make a real difference in people's lives and the planet.

Thank you for trusting us

st. gallengrid xstart global

Be part of our team

Do you believe you are ready to make a real impact on the healthcare landscape?

There are currently no open positions.
Feel free to reach us if you believe that
you can contribute to SphereBio's mission
Fight Against Cancer: An Argentine Startup is developing vaccines for its treatment
September 25, 2024
Fight Against Cancer: An Argentine Startup is developing vaccines for its treatment
View article
SphereBio designs a new platform to fight cancer recognized by MIT
May 20, 2024
SphereBio designs a new platform to fight cancer recognized by MIT
View article
Argentine Talent: Focus on Health
April 12, 2024
Argentine Talent: Focus on Health
View article
Five Argentine startups to keep an eye on in 2024
January 4, 2024
Five Argentine startups to keep an eye on in 2024
View article
Endeavor "Women in Entrepreneurship" Winners
November 29, 2023
Endeavor "Women in Entrepreneurship" Winners
View article
Brazil South Summit Finalists
March 20, 2024
Brazil South Summit Finalists
View article
MIT IDEA2
January 5, 2024
MIT IDEA2
View article
News & Press Release

Keep in the know

We know that science and innovation move fast, and we want you to be a part of the action.